Researchers from MIT and Scripps have unveiled a promising new HIV vaccine approach that generates a powerful immune response ...

The Trump administration's plan to cut funding for HIV vaccine research comes at a time when the field is making substantial ...

The approach employed by the research team could be used against other diseases—including COVID-19 and influenza.

On May 30, a team of researchers funded by the National Institutes of Health got the word: Funding for their vaccine ...

The Trump administration has ended a program seeking a vaccine for HIV, the first in a series of decisions that is leaving ...

Groundbreaking single-dose vaccine found effective in preventing HIV - Strategy may lead to new vaccines that only need to be ...

The breakthrough double injection won’t be cheap in the US, although scientists argue it could (and should) be.

In the quest to develop an effective HIV vaccine, scientists from Scripps Research have made a significant leap forward. They ...

Experts and advocates say that twice-a-year HIV PrEP injections have the prevention potential of a vaccine — and that a once-a-year version of lenacapavir would be even better. But will Yeztugo be ...

There is still no cure or effective vaccine for HIV, but scientists have opened up new possibilities in HIV treatment and ...

Immuno Cure Biotech Ltd. is collaborating with Pharmajet Inc. to evaluate the safety and immunogenicity of its HIV ...